Immunomedics Inc. announced on Wednesday some leadership changes as well as a business update on how it’s been navigating the COVID-19 landscape.
The Morris Plains-based biopharmaceutical firm said Harout Semerjian, CEO and president, has stepped down rom his role, effective immediately. Also, Dr. Behzad Aghazadeh, executive chairman, will continue to support the company in an executive leadership role moving forward.
“This decision … is precipitated by the unfortunate significant logistical obstacles presented by the COVID-19 pandemic, including Mr. Semerjian’s ability to fully assume his duties as CEO,” the company said in a news release.
Other business updates:
- It has resumed its study of Trodelvy at about 20 clinical sites, with more to open in the following weeks;
- Manufacturing continues to operate at capacity across its supply chain with minimal impact from the coronavirus.
The company said it is not expecting to start a CEO search until the global pandemic has stabilized.